Re: SF
|
2
|
Resverlogix Corp.
|
Sep 16, 2020 07:03PM
|
Re: Presentation up on YouTube
|
2
|
Resverlogix Corp.
|
Sep 24, 2020 05:45PM
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
2
|
Resverlogix Corp.
|
May 09, 2022 03:16PM
|
Re: RBC unregistered to registered account
|
2
|
Zenith Epigenetics
|
Apr 02, 2019 07:47AM
|
Re: New-Report of exempt distribution
|
2
|
Resverlogix Corp.
|
Jan 06, 2021 09:58AM
|
Re: Final Short Term Prospectus and other Related Documents now on SEDAR
|
2
|
Resverlogix Corp.
|
Jun 04, 2019 04:04PM
|
Re: Article
|
2
|
Resverlogix Corp.
|
Oct 25, 2020 12:17PM
|
Re: Financial Future
|
2
|
Resverlogix Corp.
|
May 14, 2019 10:12AM
|
Number of Directors
|
2
|
Resverlogix Corp.
|
Sep 29, 2019 12:48PM
|
Re: Financial Statement Q2, 2023 /MD&A
|
2
|
Resverlogix Corp.
|
Aug 14, 2023 08:37AM
|
Re: Breakthrough Therapy Question
|
2
|
Resverlogix Corp.
|
Jan 05, 2020 07:21PM
|
Re: Good news for RVX…maybe
|
2
|
Resverlogix Corp.
|
Jul 09, 2021 12:10PM
|
Re: So I was able to finally set up a one on one meeting with...
|
2
|
Resverlogix Corp.
|
Mar 16, 2022 08:29AM
|
Re: Book closes.....
|
2
|
Resverlogix Corp.
|
Jun 04, 2019 04:41PM
|
Patent Applications in U.S. and Europe
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 24, 2019 04:20PM
|
Re: Long-haulers get better after getting vaccine
|
2
|
Resverlogix Corp.
|
Apr 09, 2021 10:28AM
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 23, 2018 10:31AM
|
Re: Financials/MD&A -SEDAR June 30/22
|
2
|
Resverlogix Corp.
|
Aug 13, 2022 11:18AM
|
Re: Breakthrough Therapy Question
|
2
|
Resverlogix Corp.
|
Jan 05, 2020 07:48PM
|
Re: Resverlogix warrants to be delisted June 21
|
2
|
Resverlogix Corp.
|
Jun 14, 2021 03:36PM
|